Real-world monitoring of circulating tumor DNA reliably predicts cancer recurrence in patients with resected stages I-III colorectal cancer

被引：2

作者：

Cohen, S. A. ^{[1
,2
]}

Kasi, P. M. ^{[3
]}

Aushev, V. N. ^{[4
]}

Hanna, D. L. ^{[5
]}

Botta, G. P. ^{[6
]}

Sharif, S. ^{[7
]}

Laliotis, G. ^{[4
]}

Sharma, S. ^{[4
]}

Sharma, V. ^{[8
]}

Alqahtani, A. ^{[9
]}

Chandana, S. R. ^{[10
]}

Kang, S. ^{[11
]}

Chakrabarti, S. ^{[12
]}

Somer, B. G. ^{[13
]}

Kasi, A. ^{[14
]}

Dayyani, F. ^{[15
]}

Malla, M. ^{[16
]}

Jurdi, A. ^{[4
]}

Aleshin, A. ^{[4
]}

Kopetz, S. ^{[17
]}

机构：

[1] Univ Washington, Med Oncol, Seattle, WA USA

[2] Fred Hutchinson Canc Ctr, Seattle, WA USA

[3] New York Presbyterian Hosp, Englander Inst Precis Med, Oncol Hematol Dept, Weill Cornell Med, New York, NY USA

[4] Natera Inc, Oncol, Austin, TX USA

[5] USC Univ Southern Calif, Med Oncol, Norris Comprehens Canc Ctr, Los Angeles, CA USA

[6] UCSD Moores Canc Ctr, Div Hematol Oncol, Med, La Jolla, CA USA

[7] Univ Iowa, Med Oncol, Holden Comprehens Canc Ctr, Iowa City, IA USA

[8] James Graham Brown Canc Ctr, Med Oncol, Louisville, KY USA

[9] Georgetown Univ, Ruesch Ctr Cure Gastrointestinal Canc, Lombardi Comprehens Canc Ctr, Med Oncol,Med Ctr, Washington, DC USA

[10] Canc & Hematol Ctr Western Michigan, Oncol Hematol Dept, Grand Rapids, MI USA

[11] Emory Univ, Oncol Hematol Dept, Winship Canc Inst, Atlanta, GA USA

[12] Med Coll Wisconsin, Med Oncol, Milwaukee, WI USA

[13] West Canc Ctr, Med Oncol, Germantown, TN USA

[14] KUMC Univ Kansas Med Ctr, Med Oncol, Kansas City, KS USA

[15] Univ Calif Irvine, Med Dept, Chao Family Comprehens Canc Ctr, Orange, CA USA

[16] West Virginia Univ, Hematol Oncol, Inst Canc, Morgantown, WV USA

[17] Univ Texas MD Anderson Canc Ctr, GI Med Oncol Dept, Houston, TX USA

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期

关键词：

D O I：

10.1016/j.annonc.2022.07.457

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

319MO

引用

页码：S683 / S684

页数：2

共 50 条

[31] Real-world treatment patterns in older patients with stage I-III breast cancer: A population-based study
Batra, Atul
Kong, Shiying
Rigo, Rodrigo
Cheung, Winson Y.
CANCER RESEARCH, 2021, 81 (04)
[32] Real-world treatment patterns in resectable (stages I-III) non-small-cell lung cancer: a systematic literature review
Waser, Nathalie
Vo, Lien
McKenna, Mike
Penrod, J. R.
Goring, Sarah
FUTURE ONCOLOGY, 2022, 18 (12) : 1519 - 1530
[33] Research Prognostic evaluation of esophageal cancer patients with stages I-III
Qiu, Meng-jun
Yang, Sheng-li
Wang, Meng-meng
Li, Ya-nan
Jiang, Xin
Huang, Zao-zao
Xiong, Zhi-fan
AGING-US, 2020, 12 (14): : 14736 - 14753
[34] DNA Methylation Predicts Recurrence From Resected Stage III Proximal Colon Cancer
Ahn, Joong Bae
Chung, Woon Bok
Maeda, Osamu
Shin, Sang Joon
Kim, Hyun Soo
Chung, Hyun Chul
Kim, Nam Kyu
Issa, Jean-Pierre J.
CANCER, 2011, 117 (09) : 1847 - 1854
[35] Circulating tumor DNA dynamics as an early predictor of recurrence in patients with radically resected colorectal cancer: GALAXY study in the CIRCULATE-Japan
Mishima, Saori
Kotani, Daisuke
Nakamura, Yoshiaki
Bando, Hideaki
Miyo, Masaaki
Hamabe, Atsushi
Watanabe, Jun
Hirata, Keiji
Akazawa, Naoya
Kataoka, Kozo
Yeh, Kun-Huei
Laliotis, George
Jurdi, Adham
Liu, Minetta
Taniguchi, Hiroya
Takemasa, Ichiro
Kato, Takeshi
Yoshino, Takayuki
Oki, Eiji
ANNALS OF ONCOLOGY, 2023, 34 : S1385 - S1385
[36] Overall survival after recurrence in stage I-III colorectal cancer patients in accordance with the recurrence organ site and pattern
Sawayama, Hiroshi
Miyamoto, Yuji
Hiyoshi, Yukiharu
Ogawa, Katsuhiro
Kato, Rikako
Akiyama, Takahiko
Kiyozumi, Yuki
Yoshida, Naoya
Baba, Hideo
ANNALS OF GASTROENTEROLOGICAL SURGERY, 2021, 5 (06): : 813 - 822
[37] Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management
Wehrle, Julius
Philipp, Ulrike
Jolic, Martina
Follo, Marie
Hussung, Saskia
Waldeck, Silvia
Deuter, Max
Rassner, Michael
Braune, Jan
Rawluk, Justyna
Greil, Christine
Waller, Cornelius F.
Becker, Heiko
Duque-Afonso, Jesus
Illert, Anna L.
Fritsch, Ralph M.
Meiss, Frank
Duyster, Justus
von Bubnoff, Nikolas
Scherer, Florian
DIAGNOSTICS, 2020, 10 (08)
[38] Longitudinal dynamics of circulating tumor DNA for treatment monitoring in patients with breast cancer recurrence
Yoo, Tae-Kyung Robyn
Lee, Ji-Young
Park, Hwan
Cho, Whi-Kyung
Jeon, Seyeon
Jun, Ha Ra
Lee, Sae Byul
Chung, Il Yong
Kim, Hee Jeong
Ko, Beom Seok
Lee, Jong Won
Son, Byung Ho
Ahn, Sei-Hyun
Jeong, Jae Ho
Kim, Jeong Eun
Ahn, Jin-Hee
Jung, Kyung Hae
Kim, Sung-Bae
Lee, Hee Jin
Gong, Gyungyub
Kim, Jisun
Chun, Sung-Min
SCIENTIFIC REPORTS, 2024, 14 (01):
[39] Clinical and pathological features associated with circulating tumor DNA content in real-world patients with metastatic prostate cancer
Antonarakis, Emmanuel S.
Tierno, Marni
Fisher, Virginia
Tukachinsky, Hanna
Alexander, Sonja
Hamdani, Omar
Hiemenz, Matthew C.
Huang, Richard S. P.
Oxnard, Geoffrey R.
Graf, Ryon P.
PROSTATE, 2022, 82 (07): : 867 - 875
[40] Comprehensive Genomic Profiling of Circulating Tumor DNA in Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of a Real-World Healthcare Claims Database
Nakamura, Yoshiaki
Olsen, Steven
Zhang, Nicole
Liao, Jiemin
Yoshino, Takayuki
CURRENT ONCOLOGY, 2022, 29 (05) : 3433 - 3448

← 1 2 3 4 5 →